143 related articles for article (PubMed ID: 31262600)
1. A systematic review of risk-reducing cancer surgery outcomes for hereditary cancer syndromes.
Peacock O; Waters PS; Otero de Pablos J; Boussioutas A; Skandarajah A; Simpson JA; Warrier SK; Heriot AG
Eur J Surg Oncol; 2019 Dec; 45(12):2241-2250. PubMed ID: 31262600
[TBL] [Abstract][Full Text] [Related]
2. Risk-reduction surgery in pediatric surgical oncology: A perspective.
Sandoval JA; Fernandez-Pineda I; Malkan AD
J Pediatr Surg; 2016 Apr; 51(4):675-87. PubMed ID: 26898681
[TBL] [Abstract][Full Text] [Related]
3. Quality-of-life implications of risk-reducing cancer surgery.
Altman AM; Hui JYC; Tuttle TM
Br J Surg; 2018 Jan; 105(2):e121-e130. PubMed ID: 29341149
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
5. Hereditary cancer syndromes with high risk of endometrial and ovarian cancer: surgical options for personalized care.
McCann GA; Eisenhauer EL
J Surg Oncol; 2015 Jan; 111(1):118-24. PubMed ID: 25139656
[TBL] [Abstract][Full Text] [Related]
6. [Prophylactic surgery in common hereditary cancer syndromes].
Noguès C; Mouret-Fourme E
Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT; van Kessel JP; van Dieren JM; Snaebjornsson P; Balagué O; van Coevorden F; van der Kolk LE; Sikorska K; Cats A; van Sandick JW
Br J Surg; 2018 Jan; 105(2):e176-e182. PubMed ID: 29341148
[TBL] [Abstract][Full Text] [Related]
8. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K; ;
J Clin Oncol; 2006 Oct; 24(28):4642-60. PubMed ID: 17008706
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic surgery in hereditary cancer syndromes: an ounce of prevention may be the only cure.
Bilimoria MM
J Surg Oncol; 2002 Mar; 79(3):131-3. PubMed ID: 11870660
[No Abstract] [Full Text] [Related]
10. Prophylactic thyroidectomy: who needs it, when, and why.
Wang TS; Opoku-Boateng A; Roman SA; Sosa JA
J Surg Oncol; 2015 Jan; 111(1):61-5. PubMed ID: 24965542
[TBL] [Abstract][Full Text] [Related]
11. The role of prophylactic surgery in cancer prevention.
You YN; Lakhani VT; Wells SA
World J Surg; 2007 Mar; 31(3):450-64. PubMed ID: 17308850
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic surgery in hereditary breast/ovarian cancer syndrome.
Levine DA; Gemignani ML
Oncology (Williston Park); 2003 Jul; 17(7):932-41; discussion 946-8, 950-2. PubMed ID: 12886864
[TBL] [Abstract][Full Text] [Related]
13. ASCO/SSO review of current role of risk-reducing surgery in common hereditary cancer syndromes.
Guillem JG; Wood WC; Moley JF; Berchuck A; Karlan BY; Mutch DG; Gagel RF; Weitzel J; Morrow M; Weber BL; Giardiello F; Rodriguez-Bigas MA; Church J; Gruber S; Offit K
Ann Surg Oncol; 2006 Oct; 13(10):1296-321. PubMed ID: 16990987
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic oophorectomy.
Coukos G; Rubin SC
Best Pract Res Clin Obstet Gynaecol; 2002 Aug; 16(4):597-609. PubMed ID: 12413937
[TBL] [Abstract][Full Text] [Related]
15. Perioperative Management of Women Undergoing Risk-reducing Surgery for Hereditary Breast and Ovarian Cancer.
AlHilli MM; Al-Hilli Z
J Minim Invasive Gynecol; 2019 Feb; 26(2):253-265. PubMed ID: 30240898
[TBL] [Abstract][Full Text] [Related]
16. Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.
Franceschini G; Di Leone A; Terribile D; Sanchez MA; Masetti R
Ann Ital Chir; 2019; 90():1-2. PubMed ID: 30872561
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic mastectomy for the prevention of breast cancer.
Lostumbo L; Carbine N; Wallace J; Ezzo J
Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
[TBL] [Abstract][Full Text] [Related]
18. Hereditary ovarian cancer.
Russo A; Calò V; Bruno L; Rizzo S; Bazan V; Di Fede G
Crit Rev Oncol Hematol; 2009 Jan; 69(1):28-44. PubMed ID: 18656380
[TBL] [Abstract][Full Text] [Related]
19. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Bogani G; Tagliabue E; Signorelli M; Chiappa V; Carcangiu ML; Paolini B; Casarin J; Scaffa C; Gennaro M; Martinelli F; Borghi C; Ditto A; Lorusso D; Raspagliesi F
J Minim Invasive Gynecol; 2017; 24(5):837-842. PubMed ID: 28479170
[TBL] [Abstract][Full Text] [Related]
20. Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer.
Bercow AS; Eisenhauer EL
J Surg Oncol; 2019 Oct; 120(5):864-872. PubMed ID: 31355450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
